1. Home
  2. IKNA vs EHGO Comparison

IKNA vs EHGO Comparison

Compare IKNA & EHGO Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • IKNA
  • EHGO
  • Stock Information
  • Founded
  • IKNA 2016
  • EHGO 2015
  • Country
  • IKNA United States
  • EHGO China
  • Employees
  • IKNA N/A
  • EHGO N/A
  • Industry
  • IKNA Biotechnology: Pharmaceutical Preparations
  • EHGO
  • Sector
  • IKNA Health Care
  • EHGO
  • Exchange
  • IKNA Nasdaq
  • EHGO NYSE
  • Market Cap
  • IKNA 81.6M
  • EHGO 90.4M
  • IPO Year
  • IKNA 2021
  • EHGO 2024
  • Fundamental
  • Price
  • IKNA $1.45
  • EHGO $1.12
  • Analyst Decision
  • IKNA Buy
  • EHGO
  • Analyst Count
  • IKNA 2
  • EHGO 0
  • Target Price
  • IKNA $3.00
  • EHGO N/A
  • AVG Volume (30 Days)
  • IKNA 134.5K
  • EHGO 586.9K
  • Earning Date
  • IKNA 03-11-2025
  • EHGO 02-15-2025
  • Dividend Yield
  • IKNA N/A
  • EHGO N/A
  • EPS Growth
  • IKNA N/A
  • EHGO N/A
  • EPS
  • IKNA N/A
  • EHGO 0.00
  • Revenue
  • IKNA $659,000.00
  • EHGO $16,963,957.00
  • Revenue This Year
  • IKNA N/A
  • EHGO N/A
  • Revenue Next Year
  • IKNA N/A
  • EHGO N/A
  • P/E Ratio
  • IKNA N/A
  • EHGO $2,984.89
  • Revenue Growth
  • IKNA N/A
  • EHGO N/A
  • 52 Week Low
  • IKNA $1.22
  • EHGO $0.91
  • 52 Week High
  • IKNA $1.94
  • EHGO $5.50
  • Technical
  • Relative Strength Index (RSI)
  • IKNA 36.12
  • EHGO N/A
  • Support Level
  • IKNA $1.45
  • EHGO N/A
  • Resistance Level
  • IKNA $1.53
  • EHGO N/A
  • Average True Range (ATR)
  • IKNA 0.06
  • EHGO 0.00
  • MACD
  • IKNA -0.00
  • EHGO 0.00
  • Stochastic Oscillator
  • IKNA 23.53
  • EHGO 0.00

About IKNA Ikena Oncology Inc.

Ikena Oncology Inc is a targeted oncology company developing precision therapies for patients in need that target nodes of cancer growth, spread, and therapeutic resistance in the Hippo and RAS onco-signaling network. Its targeted oncology product candidate, IK-930, is an oral small-molecule inhibitor of the transcriptional enhanced associate domain, or TEAD, a transcription factor in the Hippo signaling pathway, a known oncogenic pathway that also drives resistance to multiple targeted and chemotherapies. Its other product candidates are IK-175 and IK-595.

About EHGO ESHALLGO INC

Eshallgo Inc. focuses on two distinct market sectors: office supply sale and leasing, and after-sale maintenance and repair. It is an authorized distributor of brands of office equipment, including HP, Epson, Xerox, Sharp, Toshiba, Konica, Kyocera, and other brands.

Share on Social Networks: